Bloomberg -- GlaxoSmithKline Plc, the U.K.’s biggest drugmaker, said it has come up with an antibiotic designed to circumvent the drug resistance that makes many hospital-acquired infections difficult to treat.
Bloomberg -- GlaxoSmithKline Plc, the U.K.’s biggest drugmaker, said it has come up with an antibiotic designed to circumvent the drug resistance that makes many hospital-acquired infections difficult to treat.
